Literature DB >> 7836062

The peptide-binding specificity of HLA-B27 subtype (B*2705) analyzed by the use of polyalanine model peptides.

D Fruci1, G Greco, E Vigneti, N Tanigaki, R H Butler, R Tosi.   

Abstract

Model peptides have been used to quantitate the effect on HLA-B*2705 binding of the spacing between primary anchor residues, the type of amino acid accepted in the P9 anchor position, and the type of amino acid accepted in the "secondary anchor positions" P3 and P7. Peptide binding was measured by the HLA class I alpha-chain-refolding assay. The results obtained show that (a) Among the model peptides differing in the spacing between anchor residues, the nonamer with Arg in P2 and Lys in P9 (R2, K9) has the maximum binding with B*2705 molecule. The decamer, with an extra Ala inserted between Arg and Lys (R2, K10), has much lower binding, and still lower binding is observed for the octamer, where an Ala is removed (R2, K8). (b) Besides the "classic" Lys and Arg, several other aminoacids such as Tyr, Leu, Ala, and Gln can be accepted in P9, but with significant differences in binding affinity. (c) Different amino acids in P3 have an influence on peptide binding. Trp and Phe have a favorable influence, whereas Lys and Val appear to hinder the binding. Some variations are seen also for different amino acids in P7.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7836062     DOI: 10.1016/0198-8859(94)90081-7

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  5 in total

1.  Differences in peptide-binding specificity of two ankylosing spondylitis-associated HLA-B27 subtypes.

Authors:  D Fruci; R H Butler; G Greco; P Rovero; L Pazmany; E Vigneti; R Tosi; N Tanigaki
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  The Asp116-His116 substitution in a novel HLA-B27 subtype influences the acceptance of the peptide C-terminal anchor.

Authors:  M T Fiorillo; G Greco; R Sorrentino
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  The role of HLA class I gene variation in autoimmune diabetes.

Authors:  Charles Sia; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2005-08-10

4.  Modulation of Natural HLA-B*27:05 Ligandome by Ankylosing Spondylitis-associated Endoplasmic Reticulum Aminopeptidase 2 (ERAP2).

Authors:  Elena Lorente; Miguel G Fontela; Eilon Barnea; Antonio J Martín-Galiano; Carmen Mir; Begoña Galocha; Arie Admon; Pilar Lauzurica; Daniel López
Journal:  Mol Cell Proteomics       Date:  2020-04-07       Impact factor: 5.911

5.  The peptide-binding motif for the human transporter associated with antigen processing.

Authors:  P M van Endert; D Riganelli; G Greco; K Fleischhauer; J Sidney; A Sette; J F Bach
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.